Semaxanib

InformationDS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.TargetsIDH1 R132XIn vitroDS-1001b impairs the proliferation of

InformationDS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.TargetsIDH1 R132XIn vitroDS-1001b impairs the proliferation of

InformationDS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.TargetsIDH1 R132XIn vitroDS-1001b impairs the proliferation of

A cell-permeable pyrido-pyrimidinedione derivative that acts as a highly potent and selective inhibitor of eukaryotic elongation factor-2 kinase (eEF2K) (IC 50 = 280 nM). Exhibits very little activity against a broad panel of serine/threonine and

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

InformationEltanexor (KPT-8602) Eltanexor (KPT-8602, ONO-7706，ATG-016) is a second-generation, orally bioavailable XPO1 (also known as CRM1) inhibitor with IC50 values of 20−211 nM in 10 AML lines after 3 days exposure.TargetsXPO1In vitroKPT-8602 is

Formula: Ga2Se3 Formula weight: 376.33 Purity: 99.99% (metals basis) CAS Number: 12024-24-7 UN Number: UN3077 Hazard Class: </str

Cell Line Origin Human ovarian epithelial-serous carcinoma, sigmoid Cell Line Description A human ovarian epithelial-serous carcinoma cell line established from a metastasis of the sigmoid colon. This cell line was derived from the same patient